This inventor holds 9 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Duality Biologics (Suzhou) Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2022-2026.
Location History:
- Jiangsu, CN (2022)
- Shanghai, CN (2023 - 2024)
Company Filing History:
6 out of 7 
2 out of 8 
2 out of 8 Years Active: 2022-2026
Title: **The Innovative Journey of Inventor Haiqing Hua**
Introduction
Haiqing Hua is a prominent inventor based in Shanghai, China, known for his groundbreaking contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, Hua has focused his research on developing anti-tumor compounds that aim to advance cancer treatment.
Latest Patents
Among his noteworthy patents is the "Anti-tumor compound and preparation method and use thereof." This patent details a novel anti-tumor compound along with its preparation methods. The invention includes various forms of the compound, such as tautomers, mesomers, racemates, enantiomers, diastereoisomers, and their pharmaceutically acceptable salts. This innovative approach demonstrates Hua's commitment to enhancing therapeutic options in oncology.
Career Highlights
Haiqing Hua is currently associated with Duality Biologics (Suzhou) Co., Ltd., where he continues to push the boundaries of medical research. His work at this biopharmaceutical company has positioned him as a key player in the design and development of innovative treatment solutions.
Collaborations
Throughout his career, Hua has collaborated with other esteemed professionals, including Yu Zhang and Zhongyuan Zhu. These collaborations have fostered an environment of shared knowledge and innovation, amplifying the impact of his work in the pharmaceutical sector.
Conclusion
Haiqing Hua’s contributions to the field of anti-tumor therapies highlight his role as an influential inventor. With a solid patent portfolio and ongoing collaborations, he continues to pave the way for innovative solutions that could benefit patients around the world. His work exemplifies the vital connection between research and real-world applications in the fight against cancer.